A New Mdr2−/− Mouse Model of Sclerosing Cholangitis with Rapid Fibrosis Progression, Early-Onset Portal Hypertension, and Liver Cancer
Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice
Extrahepatic Platelet-Derived Growth Factor-β, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice
Failure of Fibrotic Liver Regeneration in Mice Is Linked to a Severe Fibrogenic Response Driven by Hepatic Progenitor Cell Activation
Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.
Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis and fibrosis
CFTR dysfunction predisposes to fibrotic liver disease in a murine model
Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity: MMP expression in obesity and fatty liver
Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease
Hepatitis c virus-specific t-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis: Hepatology
Tumor Necrosis Factor α-Converting Enzyme Inhibition Reverses Hepatic Steatosis and Improves Insulin Sensitivity Markers and Surgical Outcome in Mice
Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in Mice
Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42
Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells
Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in Mice
Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis
Role of the receptor for advanced glycation end products in hepatic fibrosis.
Gliadin-primed CD4+CD45RBlowCD25- T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice
Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis
Rationale and targets for antifibrotic therapies.
Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans
Inhibition of Integrin αvβ6 on Cholangiocytes Blocks Transforming Growth Factor-β Activation and Retards Biliary Fibrosis Progression
The hedgehog pathway regulates remodelling responses to biliary obstruction in rats
Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies
Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro
Halofuginone Induces Matrix Metalloproteinases in Rat Hepatic Stellate Cells via Activation of p38 and NF B
Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat
Hepatitis C Virus-Replicating Hepatocytes Induce Fibrogenic Activation of Hepatic Stellate Cells
Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential.
Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes
Hepatic fibrosis: From bench to bedside
Antiatherogenic effects of 17 beta-estradiol and 17 alpha-estradiol and its derivative J811 in cholesterol-fed rabbits with thyroid inhibition.
Scavenging and antioxidant effects of estrogen derivatives in cholesterol-fed rabbits.
Scavenging and Antioxidant Effects of Estrogen Derivatives in Cholesterol-Fed Rabbits
Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies
Mouse model of PBC with progressive fibrosis: Are we there yet?
Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Dead or Alive?
CD8+ T cells drive adipose tissue inflammation – A novel clue for NASH pathogenesis?